Agios Chief Commercial Officer Buys 8,475 Shares in Market‑Neutral Trade, Signaling Confidence Ahead of Big Biotech Conference.
Agios insider buy: CCO Milanova Tsveta adds 8,475 shares, showing confidence after the 52‑week low and hinting at upcoming pipeline data.
2 minutes to read